[go: up one dir, main page]

AU2003276149A1 - Methods for treating viral diseases using modulators of amyloidogenic peptide aggregation - Google Patents

Methods for treating viral diseases using modulators of amyloidogenic peptide aggregation

Info

Publication number
AU2003276149A1
AU2003276149A1 AU2003276149A AU2003276149A AU2003276149A1 AU 2003276149 A1 AU2003276149 A1 AU 2003276149A1 AU 2003276149 A AU2003276149 A AU 2003276149A AU 2003276149 A AU2003276149 A AU 2003276149A AU 2003276149 A1 AU2003276149 A1 AU 2003276149A1
Authority
AU
Australia
Prior art keywords
modulators
methods
viral diseases
treating viral
peptide aggregation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003276149A
Other versions
AU2003276149A8 (en
Inventor
David I. Israel
Tajib Mirzabekov
Joseph Sodroski
Woj M. Wojtowicz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Praecis Pharmaceuticals Inc
Original Assignee
Praecis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Praecis Pharmaceuticals Inc filed Critical Praecis Pharmaceuticals Inc
Publication of AU2003276149A1 publication Critical patent/AU2003276149A1/en
Publication of AU2003276149A8 publication Critical patent/AU2003276149A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003276149A 2002-06-18 2003-06-18 Methods for treating viral diseases using modulators of amyloidogenic peptide aggregation Abandoned AU2003276149A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US39004002P 2002-06-18 2002-06-18
US60/390,040 2002-06-18
US39439002P 2002-07-08 2002-07-08
US60/394,390 2002-07-08
PCT/US2003/019365 WO2003105677A2 (en) 2002-06-01 2003-06-18 Methods for treating viral diseases using modulators of amyloidogenic peptide aggregation

Publications (2)

Publication Number Publication Date
AU2003276149A1 true AU2003276149A1 (en) 2003-12-31
AU2003276149A8 AU2003276149A8 (en) 2003-12-31

Family

ID=29740198

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003276149A Abandoned AU2003276149A1 (en) 2002-06-18 2003-06-18 Methods for treating viral diseases using modulators of amyloidogenic peptide aggregation

Country Status (2)

Country Link
AU (1) AU2003276149A1 (en)
WO (1) WO2003105677A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008145721A2 (en) * 2007-06-01 2008-12-04 Novo Nordisk A/S N-terminal modification of polypeptides for protection against degradation by aminopeptidases
US12215173B2 (en) 2019-08-07 2025-02-04 HUMANWELL PHARMACEUTICAL US, Inc. Kappa opioid receptor peptide amide ligands
KR102130281B1 (en) * 2020-06-19 2020-07-08 성균관대학교산학협력단 A pharmaceutical composition for preventing or treating a human cytomegalovirus disease comprising a gamma secretase inhibitor, and a method for screening a therapeutic agent for a human cytomegalovirus disease using gamma secretase
AU2020454871A1 (en) 2020-06-25 2023-01-19 Humanwell Pharmaceutical US Peptides for treatment of medical disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804560A (en) * 1995-01-06 1998-09-08 Sibia Neurosciences, Inc. Peptide and peptide analog protease inhibitors
US5948763A (en) * 1995-06-07 1999-09-07 New York University Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits

Also Published As

Publication number Publication date
WO2003105677A2 (en) 2003-12-24
AU2003276149A8 (en) 2003-12-31
WO2003105677A3 (en) 2004-03-04

Similar Documents

Publication Publication Date Title
AU2003249682A1 (en) Treatment of neurodegenerative diseases using proteasome modulators
AU2002332430A1 (en) Methods of treating neuropilin-mediated diseases
WO2003033720A8 (en) Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders
AU2003286567A1 (en) Methods for the treatment of skin disorders
AU2003261251A1 (en) Methods of delivering therapeutic agents
AU2003225281A1 (en) Materials and methods for prevention and treatment of rna viral diseases
AU2002334870B8 (en) Combinations for the treatment of immunoinflammatory disorders
AU2003220521A1 (en) Methods of treatment with lxr modulators
AU2003279240A1 (en) Methods for purifying viral particles for gene therapy
AU2003225670A1 (en) Interferon drug therapy for the treatment of viral diseases and liver fibrosis
AU2003267532A1 (en) PEPTIDES AND PEPTIDE DERIVATIVES FOR THE TREATMENT OF Alpha-SYNUCLEIN-RELATED DISEASES
AU2003223684A1 (en) Lxr modulators for the treatment of cardiovascular diseases
AU2002359459A1 (en) Treating b-cell mediated diseases by modulating dr6 activity
AU2003299962A1 (en) Interferon drug therapy for the treatment of viral diseases and liver fibrosis
AU2003259833A1 (en) Methods of treating neurodegenerative diseases
AU2003276149A1 (en) Methods for treating viral diseases using modulators of amyloidogenic peptide aggregation
AU2003230004A1 (en) Methods of therapy for inducing tolerance
AU2003237493A1 (en) Methods for treating diseases or conditions with peptide constructs
AU2003274320A1 (en) Electrodes for therapeutic apparatus
AU2003303381A1 (en) Methods for treating malaria by modulation of g protein function
AU2002359310A1 (en) Treating diseases mediated by metalloprotease-shed proteins
AU2003243215A1 (en) Treatment for human papillomavirus
AU2003256701A1 (en) Methods of modulating proliferative conditions
AU2003254447A1 (en) Treatment of proliferative disorders
AU2003293581A1 (en) Method of identifying therapeutic agents

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase